Taken together, these studies support the notion that the CD58 molecule plays a vital role in tumor cell biology and highlight that regulation of the adhesion molecule CD58 on the surface of tumor cells may be a promising immunotherapeutic strategy. Here, CD58 is linked to neoplasm.